ANANTHALAKSHMI RAMAMOORTHY1, SUNITHA JANARDHANAN2, SATHIYAJEEVA JEEVAKARUNYAM3,NADHEEM JEDDY4, SENTHIL EAGAPPAN5

Complementary and Alternative Medicine (CAM) in the United States

by Alexandre Vallée &Yves Lecarpentier

Can we learn anything about coronavirus defense from this recent study?

Study charts the “incipient supernova” of COVID-19 through genetic mutations as it spread from China and Asia to Australia, Europe and North America. Researchers say their methods could be used to help identify undocumented infection sources.

Neuro- Acupuncturist and president, Olaking International Holistic Medicine, Dr. Qazeem Olawale, has said the Federal Government’s efforts to combat Coronavirus (COVID-19) can be boosted with integrative medicine.

One of the things which make it difficult to understand the difference between alternative and conventional medicine is the many terms and labels used to describe the two. Then, adding to the confusion is a third area of healthcare: integrative medicine.

After nearly 4 years of what some researchers saw as foot dragging, the Drug Enforcement Administration (DEA) has announced it will evaluate 37 applications to grow marijuana for medical research and proposed new rules for the prospective growers that outline how the cannabis-growing program would work.

The Covid-19, or else known as 2019-nCoV or SARS-CoV-2 virus, belongs to the family of Coronavirus. As SARS-CoV-2 belongs to the β genus Coronavirus it is closely related to MERS-CoV and SARS-CoV – which have also been reported to cause severe symptoms of pneumonia in previous pandemics. The genetic structure of 2019-nCoV has been characterised and published.[i] [ii] The main proteins in this virus and those previously identified in SARS-CoV or MERS-CoV exhibit a high similarity between them.

After the coronavirus crisis is over, Europe will need policies that can create a research ecosystem in the long run as well as ensure access to medicines to the patients who need them in a way that is sustainable for health systems today and tomorrow, a top European pharmaceutical official told EURACTIV in an interview.

plus standard care for severe coronavirus disease 2019 (G-CHAMPS)：evidence from China